Research at Taizhou Enze Medical Center in China focused on the risk priority of adverse events during all phases of ...

Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over TA1054 15 April 2025 15 April 2025 ...

The following links provide access to on-line training and QM related publications to assist Members in developing and implementing their quality management system.